From the Journals

Teens’ marijuana use higher during pregnancy


 

FROM ANNALS OF INTERNAL MEDICINE

The prevalence of marijuana use among pregnant teenagers is more than double that among teens who are not pregnant, according to a study involving 410,000 females aged 12-44 years.

For pregnant teens aged 12-17 years, the past-month prevalence of marijuana use was 14% between 2002 and 2015, compared with 6.5% for their nonpregnant peers, Nora D. Volkow, MD, director of the National Institute on Drug Abuse in Bethesda, Md., and her associates reported in a letter on April 17 (Ann Intern Med. 2017 Apr 17. doi: 10.7326/L17-0067).

Prevalence of past-month marijuana use in women, 2002-2015
Data from the 2002-2015 National Survey on Drug Use and Health showed the opposite for women aged 18-25 years: 6.2% of pregnant women had used marijuana in the past month, compared with 14.1% of those who were not pregnant. Among women aged 26-44 years, 1.8% of pregnant women and 5.2% of nonpregnant women reported marijuana use in the previous month, the investigators said.

The pattern of use in the youngest age group “may reflect underlying risky behavior common to both teen pregnancy and early substance use and suggests the importance of intervention for teenagers,” the researchers wrote. “Because of consistent overlap between use of marijuana and other substances, identification of marijuana use during pregnancy warrants evaluation for comorbid substance abuse.”

The overall annual average prevalence of marijuana use was 3.8% among the 14,400 pregnant women and 7.5% for the 395,600 nonpregnant women who responded to the survey from 2002 to 2015. The investigators also found that marijuana use was higher in the first trimester (6.4%) than in the second (3.3%) or third (1.8%) trimesters and that use was higher in pregnant black women (6.5%) than in white (3.8%) or Hispanic women(2.9%) or women of other races/ethnicities (1.4%).

Although evidence on the effects of marijuana on prenatal development is limited, “pregnant females and those considering becoming pregnant should be advised not to use marijuana or other cannabinoids recreationally or to treat nausea,” Dr. Volkow and her associates wrote.

The study was sponsored by the National Institute on Drug Abuse and the Substance Abuse and Mental Health Services Administration. Dr. Volkow reported having no financial disclosures. One coauthor reported stock ownership of Pfizer, and another reported stock ownership of Sanofi and Eli Lilly.

Recommended Reading

1 in 10 youths, 1 in 4 adults in U.S. use tobacco products
MDedge Psychiatry
Adolescents’ moderate use of digital technology tied to positive mental well-being
MDedge Psychiatry
Latuda receives FDA approval for adolescent schizophrenia treatment
MDedge Psychiatry
SSRI activation in children, adolescents often misdiagnosed as bipolar
MDedge Psychiatry
Engage parents in treatment as part of family-based therapy for anorexia
MDedge Psychiatry
Children with psychotic illness aren’t treated soon enough
MDedge Psychiatry
Medication for life
MDedge Psychiatry
Family-based treatment of anorexia promising
MDedge Psychiatry
Synthetic cannabinoid use linked to multiple risk factors
MDedge Psychiatry
Adolescent opioid use common but decreasing
MDedge Psychiatry